storyado

यह ब्लॉग खोजें

Biocon Biologics gets US FDA approval for biosimilar aflibercept Yesafili, enters US ophthalmology market

को मई 21, 2024

लिंक पाएं
Facebook
Twitter
Pinterest
ईमेल
दूसरे ऐप

लिंक पाएं
Facebook
Twitter
Pinterest
ईमेल
दूसरे ऐप

What Chandrayaan-3 lander & rover will do after Moon touchdown

India's Chandrayaan-3 mission is set to land on the Moon's surface on Wednesday, marking a major achievement for the country. After landing, the rover will begin its operations for one lunar day, collecting data from its instruments. The lander will also carry out measurements and study the lunar crust and mantle. The mission aims to explore the unexplored lunar South Pole, with the hope of finding evidence of water, which could potentially be a valuable source of clean energy.

Researchers discover new T cells, genes related to immune disorders

RIKEN Center and Kyoto University, using ReapTEC, identified T cell enhancers in rare helper T cells linked to immune conditions. Published in Science, the study used GWAS to find genetic variants and single-nucleotide polymorphisms affecting diseases like multiple sclerosis. The IL7R gene was highlighted, pointing to new treatments and showcasing a novel genomics method.

Why the global race for the lunar south pole?

The lunar south pole has become important due to its potential for scientific research and resource exploration. The region contains water ice in permanently shadowed craters, making it a valuable resource for future missions. It also features craters that preserve a fossil record of the early solar system, providing insights into its history.

Blogger द्वारा संचालित

storyado

यह ब्लॉग खोजें

Biocon Biologics gets US FDA approval for biosimilar aflibercept Yesafili, enters US ophthalmology market

टिप्पणियाँ

एक टिप्पणी भेजें